Leondios G. Kostrikis

Last updated
Leondios G. Kostrikis
NationalityCypriot
Scientific career
FieldsBiochemistry
Institutions University of Cyprus

Leondios G. Kostrikis (born 1964) is a Cypriot biochemist from Cyprus and a Professor of Biological Sciences at the University of Cyprus. In 2022, he attracted media attention with the news of having found a "deltacron" Coronavirus variant. This was subsequently debunked as a possible lab error.

Contents

Early life and education

Kostrikis was born in Cyprus. [1] He received his scientific education in biochemistry from New York University. In 1987, he received his B.Sc. degree, supported by a Fulbright Scholarship. In 1993, he received his Ph.D. [1]

Career

He moved to Aaron Diamond AIDS Research Center (ADARC) to do HIV research. In 1999, he was appointed Assistant Professor of Rockefeller University. [1] In 2003, he returned to Cyprus. He became Head of Laboratory of Biotechnology and Molecular Virology and Professor of Biological Sciences at the University of Cyprus. [1]

Spurious SARS-CoV-2 Deltacron hybrid variant

Following the emergence of COVID-19 Omicron variant, Kostrikis announced in January 2022 in local TV [2] that his Cypriot health research team in Nicosia had found a new COVID-19 variant dubbing it "Deltacron". [3] Unfortunately, indiscriminate news of the COVID-19 hybrid variant dubbed "Deltacron" spread quickly in mainstream media. [4] [5] [6] [7]

Maria Van Kerkhove (head of W.H.O.'s COVID-19 Technical Leader), Richard Neher (head of Max Planck Institute for Developmental Biology and associate professor of University of Basel), and other scientists, challenged this announcement, saying a lab mistake was a more probable explanation for Cyprus lab's finding. [8] Most experts believe it was likely due to the result of a lab error, which is possible lab contamination involving Omicron fragments in a Delta specimen. Since then, many virologists have argued that it is most likely the result of a lab contamination, which purportedly shares specific properties with two different strains. [9] [10]

Related Research Articles

<span class="mw-page-title-main">Yuen Kwok-yung</span> Hong Kong microbiologist and physician

Yuen Kwok-yung is a Hong Kong microbiologist, physician and surgeon. He is a prolific researcher, with most of his nearly 800 papers related to research on novel microbes or emerging infectious diseases. He led a team identifying the SARS coronavirus that caused the SARS pandemic of 2003–4, and traced its genetic origins to wild bats. During the ongoing COVID-19 pandemic, he has acted as expert adviser to the Hong Kong government.

<span class="mw-page-title-main">Michael Baker (epidemiologist)</span> New Zealand epidemiologist

Michael George Baker is an epidemiologist with the University of Otago. Baker is a member of the New Zealand Food Safety Authority's Academy and of the New Zealand Ministry of Health's Pandemic Influenza Technical Advisory Group (PITAG).

<span class="mw-page-title-main">Siouxsie Wiles</span> New Zealand microbiologist and science communicator

Siouxsie Wiles is a British microbiologist and science communicator. Her specialist areas are infectious diseases and bioluminescence. She is based in New Zealand.

<span class="mw-page-title-main">COVID-19 pandemic in the United States</span>

In the United States, the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in 103,436,829 confirmed cases with 1,174,676 all-time deaths, the most of any country, and the 20th-highest per capita worldwide. The COVID-19 pandemic ranks first on the list of disasters in the United States by death toll; it was the third-leading cause of death in the U.S. in 2020, behind heart disease and cancer. From 2019 to 2020, U.S. life expectancy dropped by 3 years for Hispanic and Latino Americans, 2.9 years for African Americans, and 1.2 years for white Americans. These effects persisted as U.S. deaths due to COVID-19 in 2021 exceeded those in 2020, and life expectancy continued to fall from 2020 to 2021.

The COVID-19 pandemic in the United Kingdom is a part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In the United Kingdom, it has resulted in 24,905,537 confirmed cases, and is associated with 232,112 deaths.

<span class="mw-page-title-main">COVID-19 pandemic in the Republic of Ireland</span> COVID-19 viral pandemic in the Republic of Ireland

The COVID-19 pandemic in the Republic of Ireland is a part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In Ireland, it has resulted in 1,734,486 cases and 9,648 deaths, as of 24 February 2024.

<span class="mw-page-title-main">SARS-CoV-2 in mink</span>

Both the American mink and the European mink have shown high susceptibility to SARS-CoV-2 since the earliest stages of the COVID-19 pandemic, first in mink farms across Europe, followed by mink farms in the United States. Mortality has been extremely high among mink, with 35–55% of infected adult animals dying from COVID-19 in a study of farmed mink in the U.S. state of Utah.

<span class="mw-page-title-main">Variants of SARS-CoV-2</span> Notable variants of SARS-CoV-2

Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are viruses that, while similar to the original, have genetic changes that are of enough significance to lead virologists to label them separately. SARS-CoV-2 is the virus that causes coronavirus disease 2019 (COVID-19). Some have been stated, to be of particular importance due to their potential for increased transmissibility, increased virulence, or reduced effectiveness of vaccines against them. These variants contribute to the continuation of the COVID-19 pandemic.

<span class="mw-page-title-main">SARS-CoV-2 Gamma variant</span> Variant of the virus SARS-CoV-2

The Gamma variant (P.1) was one of the variants of SARS-CoV-2, the virus that causes COVID-19. This variant of SARS-CoV-2 has been named lineage P.1 and has 17 amino acid substitutions, ten of which in its spike protein, including these three designated to be of particular concern: N501Y, E484K and K417T. It was first detected by the National Institute of Infectious Diseases (NIID) of Japan, on 6 January 2021 in four people who had arrived in Tokyo having visited Amazonas, Brazil, four days earlier. It was subsequently declared to be in circulation in Brazil. Under the simplified naming scheme proposed by the World Health Organization, P.1 was labeled Gamma variant, and was considered a variant of concern until March 2022, when it was largely displaced by the delta and omicron variants.

Jemma Louise Geoghegan is a Scottish-born evolutionary virologist, based at the University of Otago, New Zealand, who specialises in researching emerging infectious diseases and the use of metagenomics to trace the evolution of viruses. As a leader in several government-funded research projects, Geoghegan became the public face of genomic sequencing during New Zealand's response to COVID-19. Her research has contributed to the discussion about the likely cause of COVID-19 and the challenges around predicting pandemics. She was a recipient of the Young Tall Poppy Award in 2017, a Rutherford Discovery Fellowship in 2020, and the 2021 Prime Minister's Emerging Scientist Prize.

<span class="mw-page-title-main">SARS-CoV-2 Delta variant</span> Variant of SARS-CoV-2 detected late 2020

The Delta variant (B.1.617.2) was a variant of SARS-CoV-2, the virus that causes COVID-19. It was first detected in India on 5 October 2020. The Delta variant was named on 31 May 2021 and had spread to over 179 countries by 22 November 2021. The World Health Organization (WHO) indicated in June 2021 that the Delta variant was becoming the dominant strain globally.

<span class="mw-page-title-main">History of the COVID-19 pandemic in the United Kingdom</span>

This article outlines the history of the COVID-19 pandemic in the United Kingdom. Though later reporting indicated that there may have been some cases dating from late 2019, COVID-19 was confirmed to be spreading in the UK by the end of January 2020. The country was initially relatively slow implementing restrictions but a legally enforced stay-at-home order had been introduced by late March. Restrictions were steadily eased across the UK in late spring and early summer that year.

<span class="mw-page-title-main">SARS-CoV-2 Omicron variant</span> Type of the virus first detected in November 2021

Omicron (B.1.1.529) is a variant of SARS-CoV-2 first reported to the World Health Organization (WHO) by the Network for Genomics Surveillance in South Africa on 24 November 2021. It was first detected in Botswana and has spread to become the predominant variant in circulation around the world. Following the original B.1.1.529 variant, several subvariants of Omicron have emerged including: BA.1, BA.2, BA.3, BA.4, and BA.5. Since October 2022, two subvariants of BA.5 called BQ.1 and BQ.1.1 have emerged.

<span class="mw-page-title-main">Timeline of the SARS-CoV-2 Omicron variant</span>

This timeline of the SARS-CoV-2 Omicron variant is a dynamic list, and as such may never satisfy criteria of completeness. Some events may only be fully understood and/or discovered in retrospect.

Michael John Plank is an English-born professor in mathematics and statistics at the University of Canterbury, and a principal investigator at Te Pūnaha Matatini. Plank's research has focused on mechanistic mathematical and stochastic models and areas of expertise include ecological and social networks, population dynamics, epidemiological models and marine ecosystems. His work has included developing and applying models to the balanced managing of fishing sites, revitalisation of endangered languages and invasive plant and weed impact. As a Co-Lead for Covid-19 Modelling Aotearoa, a research programme established initially under Te Pūnaha Matatini but independent since 2021, he came to prominence as a COVID-19 modeller and frequent commentator in the media during the COVID-19 pandemic in New Zealand. Plank has received several awards in recognition of contributions to the field of applied mathematics, particularly for his explanations of how mathematical modelling can benefit social and ecological environments and concerns.

Tulio de Oliveira is a Brazilian, Portuguese, and South African permanent resident professor of bioinformatics at the University of KwaZulu-Natal and Stellenbosch University, South Africa, and associate professor of global health at the University of Washington. He has studied outbreaks of chikungunya, dengue, hepatitis B and C, HIV, SARS-CoV-2, yellow fever and Zika. During the COVID-19 pandemic he led the team that confirmed the discovery of the Beta variant of the COVID-19 virus in 2020 and the Omicron variant in 2021.

<span class="mw-page-title-main">SARS-CoV-2 in white-tailed deer</span>

Blood samples gathered by USDA researchers in 2021 showed that 40% of sampled white-tailed deer demonstrated evidence of SARS-CoV-2 antibodies, with the highest percentages in Michigan, at 67%, and Pennsylvania, at 44%. A later study by Penn State University and wildlife officials in Iowa showed that up to 80% of Iowa deer sampled from April 2020 through January 2021 had tested positive for active SARS-CoV-2 infection, rather than solely antibodies from prior infection. This data, confirmed by the National Veterinary Services Laboratory, alerted scientists to the possibility that white-tailed deer had become a natural reservoir for the coronavirus, serving as a potential "variant factory" for eventual retransmission back into humans.

Alexander L. Greninger is assistant director of the UW Medicine Clinical Virology Laboratory and a UW assistant professor of Laboratory Medicine. His research is focused on genomic and proteomic characterization of a variety of human viruses and bacteria, with a focus on respiratory viruses and human herpesviruses.

<span class="mw-page-title-main">Sunit Kumar Singh</span> Indian molecular biologist

Sunit Kumar Singh is an Indian molecular virologist and professor of Molecular Immunology & Virology at the Institute of Medical Sciences, Banaras Hindu University. Currently he is the director of the Dr B R Ambedkar Center for Biomedical Research (ACBR), New Delhi.

Events in the year 2022 in Cyprus.

References

  1. 1 2 3 4 "Leondios G. Kostrikis, Ph.D." Retrieved 2022-01-11.
  2. Dr. Christian Kretschmer (Arzt) (31 January 2022). "Supervariante Deltakron gibt es nicht – Fehler durch Kontamination". Gelbe Liste (in German).
  3. Georgiou, Georgios (January 8, 2022). "Cyprus Finds Covid-19 Infections That Combine Delta and Omicron". Bloomberg News . Retrieved March 14, 2022.
  4. Lee, Bruce Y. (March 12, 2022). "New 'Deltacron' Covid-19 Coronavirus Variant Is A Recombinant Of Delta And Omicron". Forbes . Retrieved March 14, 2022.
  5. Snider, Mike (March 10, 2022). "There may be a new COVID variant, Deltacron. Here's what we know about it". USA Today . Retrieved March 14, 2022.
  6. Khan, Amir (January 17, 2022). "'Deltacron': Should we worry about new COVID-19 variants merging?". Al Jazeera . Retrieved March 14, 2022.
  7. Zimmer, Carl (March 11, 2022). "New 'Deltacron' Variant Is Rare and Similar to Omicron, Experts Say". The New York Times . Retrieved March 14, 2022.
  8. Kreier, Freda (January 21, 2022). "Deltacron: the story of the variant that wasn't". Nature . Retrieved March 14, 2022.
  9. Lapid, Nancy (March 9, 2022). "Variant that combines Delta and Omicron identified; dogs sniff out virus with high accuracy". Reuters . Retrieved March 14, 2022.
  10. Gubernator, Sebastian (2022-01-10). "Experten halten angeblichen "Demikron"-Nachweis für Laborfehler" (in German). Die Welt, cited via MSN. Retrieved 2022-01-11. Translation: Experts say the "Demikron" finding is a lab mistake